ESC Premium Access

Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndrome

Congress Presentation

About the speaker

Doctor Yan Yan

Beijing Anzhen Hospital, Beijing (China)
0 follower

22 more presentations in this session

Comparison of the new oral P2Y12 inhibitor (Prasugrel/Ticagrelor) to Clopidogrel in type 2 diabetes mellitus patients with AMI

Speaker: Doctor M. Kim (Daejeon, KR)

Thumbnail

Impact of antiplatelet drugs on cholesterol level of platelet lipid rafts

Speaker: Mrs V. Rabani (Besancon, FR)

Thumbnail

Optical coherence tomography assessment of in-stent thrombus immediately after percutaneous coronary intervention in patients pretreatment with Prasugrel compared to Clopidogre

Speaker: Doctor Y. Katayama (Wakayama, JP)

Thumbnail

Circadian variation of platelets inhibition with ticagrelor

Speaker: Doctor S. Fournier (Lausanne, CH)

Thumbnail

Platelet reactivity is gender and age related

Speaker: Mr G. Vos (Nieuwegein, NL)

Thumbnail

Access the full session

Poster session 6 - Antiplatelet therapy

Speakers: Doctor Y. Yan, Doctor M. Kim, Mrs V. Rabani, Doctor Y. Katayama, Doctor S. Fournier...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk